Serum GDF15 demonstrated diagnostic sensitivity and specificity comparable to carbohydrate antigen 19-9 (CA 19-9) in distinguishing malignancies from benign neoplasms and healthy individuals [101] and even surpasses CA 19-9 in differentiating PC from chronic pancreatitis [102]. This evidence concerns the gene GDF15 and pachyonychia congenita.